[삼성제약] 주요사항보고서(자기전환사채매도결정)
11/03/2026
Company
삼성제약· 001360
SAMSUNG PHARMACEUTICAL.CO.,Ltd.
Showing 9 RSS articles and DART filings mapped to this company, sorted by time.
- Market
- LISTED
- Items
- 9
2026-Q4
View on DART
2026-Q3
[삼성제약] 주요사항보고서(전환사채권발행결정)
09/02/2026
[삼성제약] 주요사항보고서(자기전환사채만기전취득결정)
08/12/2026